Great news for pain and CNS management in RSA
Acino has collaborated with Janssen, the Pharmaceutical Company of Johnson & Johnson in South Africa, to enhance patient access to several medicines. Acino will now market and sell several of their products, focusing on pain, CNS (Central Nervous System) and Infectiology therapeutic areas in South Africa.
Recent Posts
Driving Economic Transformation through Brain Health Investment in Africa
The Johannesburg Communiqué from the Africa Task Force on Brain Health declares that investing in brain health is crucial, as it supports Africa’s economic transformation and Agenda 2063 goals while covering dementia, mental health, brain trauma, and substance abuse. This investment aligns with N...
NICE Endorses Natalizumab RRMS Treatment Expansion for Refractory Cases
NICE Expands Access to Natalizumab RRMS Treatment for Highly Active Cases
The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending natalizumab RRMS treatment o...
Bausch Health’s Strategic Growth in Latin American Pharmaceuticals Through Cardiometabolic ...
Navigating Growth in Latin American Pharmaceuticals
In the Latin American pharmaceuticals sector, Bausch Health is strategically expanding its footprint under the leadership of Vice President Fernando Zarate. The company's operati...